CBD Life Sciences, Inc. (CBDL) announced that it has achieved revenue growth of 1744.00% since February 2024, driven by product innovation and strategic expansion. The main development contents are as follows.
1. Launch of Mellow Mornings Nano-CBD Coffee Creamer, which utilizes nanotechnology to increase the bioavailability of CBD.
2. Introduction of CBD horse paste, entering the pet care market.
3. Development of a nutritional supplement powder that combines mushroom extract and ashwagandha.
4. We plan to expand to Walmart Marketplace and join Alibaba's wholesale platform in August 2024.
5. Develop new markets and distribution channels through strategic partnerships.
CEO Lisa Nelson emphasizes continued growth efforts and commitment to shareholder value. CBDL has established itself as a leader in the expanding global CBD market, which is expected to reach $47 billion by 2028.
positive
1744.00% revenue growth since February 2024 Expanding to Walmart Marketplace in August 2024 Planned expansion to Alibaba wholesale platform Innovative product launches: Nano CBD Coffee Creamer, CBD Horse Paste, Dietary Supplement Powder Strategic Partnerships open up new markets and distribution channels 10/17 /2024 – 8am
The global CBD market is projected to reach $47 billion by 2028, and CBDL's breakthrough product innovations, retail expansion, and strategic partnerships position CBDL for unparalleled growth and industry leadership. Establish.
SCOTTSDALE, AZ / ACCESSWIRE / October 17, 2024 / CBD Life Sciences, Inc. (CBDL), a pioneer in the rapidly expanding CBD and wellness industry, has grown its revenue by an impressive 1744.00% since February 2024. We proudly announce it. This exponential growth has solidified its position as a dominant force in the CBD market due to the company's relentless commitment to innovation, product diversification, and high-impact partnerships.
Shareholder value and investor confidence soar amid key milestones
CBDL's exceptional financial performance clearly demonstrates the company's growth potential and long-term value to shareholders and investors. Through strategic decisions and continuous market expansion, CBDL is implementing its vision to not only meet but exceed market demands. The company's current trajectory presents a unique opportunity for investors looking to partner with high-growth, innovative companies that are transforming the CBD industry.
Key drivers of growth and innovation
Since February 2024, CBDL has introduced cutting-edge products that have captivated consumers and opened up new revenue streams.
Mellow Mornings Nano-CBD Coffee Creamer: This revolutionary product utilizes advanced nanotechnology to increase CBD bioavailability by up to 10 times compared to traditional formulations. Available in Vanilla and Classic flavors, Mellow Mornings quickly became a bestseller, and the CBD-infused beverage is now sold at local coffee shops. The product's innovative design and growing popularity continue to contribute significantly to CBDL's revenue growth.
CBD Horse Paste: Entering the multi-billion dollar pet care market, CBDL has launched veterinarian-designed CBD Horse Paste, a product that addresses both the physical and psychological needs of horses. This launch not only diversifies our products, but also taps into an underserved and high-demand market and positions CBDL for continued growth in the animal wellness space. I did.
Dietary Supplement Powder: Building on wellness trends, CBDL introduces a powerful nutritional supplement that combines Reishi Mushroom Extract, Lion's Mane Mushroom Extract, and Ashwagandha Root Extract to help reduce stress, improve cognitive function, and more. Strengthens and provides immune support. Discussions with major US organizations regarding the use of this supplement in health programs are expected to open new avenues for significant future revenue.
Increased growth due to retail expansion
CBDL's presence on major retail platforms has been a pivotal factor in the company's success. In August 2024, the company entered the Walmart Marketplace, making it accessible to millions of new consumers. This partnership has significantly increased product awareness and sales, establishing CBDL as the mainstream choice for CBD wellness products.
CBDL plans to expand into Alibaba's wholesale platform in the future, promising further growth by providing a path to international markets and expanding global brand recognition. This move positions us to capitalize on the growing demand for premium CBD products around the world and accelerate our growth trajectory.
Strategic partnerships and new revenue channels
CBDL has entered into a strategic agreement that opens doors to new markets and expands distribution channels. These collaborations have played a key role in revenue growth of 1744.00% since the beginning of 2024 and are expected to continue to drive strong financial performance. The company is also in talks with prominent organizations in both the health and wellness space, further positioning CBDL as a key player in the evolution of the industry.
Looking to the future: positioning for sustainable growth
“Our growth this year has been exceptional, and this is just the beginning,” said Lisa Nelson, President and CEO of CBD Life Sciences. In the CBD and wellness space, our beloved shareholders and future investors can expect continued strong performance as we roll out new products, expand into international markets, and build on our existing successes. . ”
Mr. Nelson also emphasized the company's commitment to increasing shareholder value through innovation, quality and expansion. “As we close out this year, we are ramping up our efforts to maintain our growth momentum. The global wellness market is rapidly expanding, and CBDL has a pipeline of breakthrough products and strategic partnerships. I am in a position to lead that charge.”
Why invest in CBD Life Sciences, Inc.?
CBDL's commitment to product innovation, market expansion, and strategic partnerships ensures the company's sustained revenue growth and profitability. As global demand for CBD and wellness products continues to grow, CBDL offers investors an attractive opportunity to be part of a proven, industry-leading company.
CBD Life Sciences plans to end 2024 with record growth, expanding international reach, and a product portfolio that continues to resonate with diverse consumers. For investors seeking exposure to a high-growth market with significant upside potential, CBDL is a wise and strategic choice.
About CBD Life Sciences
CBD Life Sciences, Inc. (CBDL) is a leading vertically integrated CBD company specializing in the development of high-quality CBD-based nutritional supplements. The company's commitment to innovation and natural solutions is driving growth and positioning it as a leader in health and wellness.
Follow us on social media for updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-looking statements
Except for historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in the forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc.'s OTC Markets filings. This may identify certain factors that could cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release contains forward-looking statements that are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These factors include general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will deliver expected benefits; Increasing competition. Availability and cost of capital. Ability to identify, develop and achieve commercial success. The level of spending required to maintain and improve the quality of service. Economic changes. changes in laws and regulations, including norms and standards, intellectual property rights, and taxation; or other unexpected matters. our ability to secure and maintain strategic relationships and distribution agreements; The Company disclaims any intention or obligation to update or revise any forward-looking statements to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
contact address:
lisa nelson
CEO
cbdvaultaz@gmail.com
4802091720
Related images
Source: CBD Life Sciences
View the original press release at accesswire.com
FAQ
What is the revenue growth rate reported by CBD Life Sciences (CBDL)?
CBD Life Sciences (CBDL) posted an impressive earnings growth rate of 1744.00% since February 2024.
What new products has CBD Life Sciences (CBDL) recently introduced?
CBDL has launched Mellow Mornings Nano-CBD coffee creamer, CBD horse paste, and a nutritional supplement powder that combines mushroom extract and ashwagandha.
Which major retail platforms will CBD Life Sciences (CBDL) enter in August 2024?
CBD Life Sciences (CBDL) entered the Walmart Marketplace in August 2024, significantly increasing product visibility and sales.
What are CBD Life Sciences (CBDL)’s international expansion plans?
CBDL plans to expand into Alibaba's wholesale platform, providing a path to international markets and expanding global brand recognition.
